The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Tezspire AstraZeneca Pty Ltd
Product name
Tezspire
Sponsor
Accepted date
Jan-2024
Active ingredients
tezepelumab
Proposed indication
As an add-on maintenance treatment in patients with severe asthma.
Application type
A (new medicine)
Publication date
Jan-2024